A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.
Pfizer
Pfizer
Tizona Therapeutics, Inc
University of Nebraska
Takeda
Kidney Cancer Research Bureau
Adela, Inc
Second Life Therapeutics
Elephas
Novartis
Elephas
University of Pittsburgh
National Institutes of Health Clinical Center (CC)
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
The University of Texas Health Science Center at San Antonio
A2 Biotherapeutics Inc.
Washington University School of Medicine
A2 Biotherapeutics Inc.
Genentech, Inc.
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
University of Alabama at Birmingham
Cancer Research UK
DEKA Biosciences
Columbia University
Tempus AI
Arbeitsgemeinschaft medikamentoese Tumortherapie
Elevation Oncology
Sheffield Teaching Hospitals NHS Foundation Trust
University Health Network, Toronto
Rutgers, The State University of New Jersey
Universidade Federal de Pernambuco
Inhibrx Biosciences, Inc
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
European Organisation for Research and Treatment of Cancer - EORTC
University of Sydney
Washington University School of Medicine
Cedars-Sinai Medical Center
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Kineta Inc.
University Health Network, Toronto
Quadriga Biosciences, Inc.
Ludwig Institute for Cancer Research
Imperial College London
Roswell Park Cancer Institute
Pfizer
Weill Medical College of Cornell University
Hospices Civils de Lyon
SpeciCare